BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19322916)

  • 1. Down-regulation of extracellular signal-regulated kinase 1/2 activity in P-glycoprotein-mediated multidrug resistant hepatocellular carcinoma cells.
    Yan F; Wang XM; Pan C; Ma QM
    World J Gastroenterol; 2009 Mar; 15(12):1443-51. PubMed ID: 19322916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGF reverses multi-drug resistance via the p-ERK pathway in HepG2/ADM and SMMC7721/ADM hepatocellular carcinoma models.
    Yan F; Bai LP; Gao H; Zhu CM; Lin L; Kang XP
    Asian Pac J Cancer Prev; 2014; 15(6):2619-23. PubMed ID: 24761873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK1, JNK2, and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells.
    Yan F; Wang XM; Liu ZC; Pan C; Yuan SB; Ma QM
    Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):287-95. PubMed ID: 20525557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.
    Sun Z; Zhao Z; Li G; Dong S; Huang Z; Ye L; Liang H; Qu J; Ai X; Zhang W; Chen X
    Tumori; 2010; 96(1):90-6. PubMed ID: 20437864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of multidrug resistant human hepatocarcinoma cell line in nude mice.
    Zhai BJ; Shao ZY; Zhao CL; Hu K; Wu F
    World J Gastroenterol; 2006 Nov; 12(41):6614-9. PubMed ID: 17075973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound reverses multidrug resistance in human cancer cells by altering gene expression of ABC transporter proteins and Bax protein.
    Wu F; Shao ZY; Zhai BJ; Zhao CL; Shen DM
    Ultrasound Med Biol; 2011 Jan; 37(1):151-9. PubMed ID: 21084157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of human multidrug-resistant hepatocellular carcinoma cell line (HepG2/Adm) and biological characteristics evaluation].
    Zhai BJ; Wu F; Shao ZY; Hu K; Wang ZB
    Ai Zheng; 2004 Apr; 23(4):391-5. PubMed ID: 15087025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of NPM reverses multidrug resistance in human hepatoma cells via inhibition of P-glycoprotein expression.
    Luo F; Li H; Liang J; Jia H; Li X; Xiao H; He X; He J; Tian Y; Zhao H
    Mol Med Rep; 2017 Apr; 15(4):2360-2368. PubMed ID: 28259962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposome-mediated RNA interference delivery against Erk1 and Erk2 does not equally promote chemosensitivity in human hepatocellular carcinoma cell line HepG2.
    Mehdizadeh A; Somi MH; Darabi M; Farajnia S; Akbarzadeh A; Montazersaheb S; Yousefi M; Bonyadi M
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1612-1619. PubMed ID: 28058860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
    Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing MRP1-4 genes by RNA interference enhances sensitivity of human hepatoma cells to chemotherapy.
    Su Z; Liu G; Fang T; Wang Y; Zhang H; Yang S; Wei J; Lv Z; Tan L; Liu J
    Am J Transl Res; 2016; 8(6):2790-802. PubMed ID: 27398162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversing multidrug-resistant by RNA interference through silencing MDR1 gene in human hepatocellular carcinoma cells subline Bel-7402/ADM.
    Sheng L; Xiong M; Li C; Meng X
    Pathol Oncol Res; 2014 Jul; 20(3):541-8. PubMed ID: 24327315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in multidrug-resistant HCC cell line HEPG2/ADM by RNA interference.
    Li H; Zhou S; Li T; Liu Z; Wu J; Zeng G; Liu C; Gong J
    Hepatogastroenterology; 2012 Oct; 59(119):2238-42. PubMed ID: 23435138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
    Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
    World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
    Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
    Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity.
    Chen S; Wang Y; Ruan W; Wang X; Pan C
    Oncol Lett; 2014 Nov; 8(5):2333-2339. PubMed ID: 25295120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of Bim and ERKs in multidrug-resistant hepatic carcinoma cells].
    Yan F; Wang X; Ma Q; Yuan S; Jiang N
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1838-41. PubMed ID: 25537915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of inhibition of nuclear factor-kappa B gene transcription by specific miRNA in reversing multi-drug resistance of liver cancer].
    Wang L; Cai Y; Shi Y; Yao M; Pan LH; Gu JJ; Yang XL; Wu W; Yao DF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):493-499. PubMed ID: 27784426
    [No Abstract]   [Full Text] [Related]  

  • 20. MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells.
    Zheng SZ; Sun P; Wang JP; Liu Y; Gong W; Liu J
    World J Gastroenterol; 2019 Jun; 25(22):2752-2762. PubMed ID: 31235998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.